Differences between MS patient characteristics in clinical trials and real populations

Stephen Krieger, physician: We are here at the ECTRIMS conference [European Committee for Treatment and Research in Multiple Sclerosis] in Amsterdam, the Netherlands, in the fall of 2022. It’s nice to be at a personal event. A lot of new work is presented here. A piece of work from Dr Ruth Dobson and colleagues on … Read more

International committee proposes framework for MS disease progression driven by pathophysiological mechanisms, not clinical phenotype

For many years, multiple sclerosis (MS) has been defined by 3 clinical courses: relapsing-remitting, primary progressive, and secondary progressive. Now, however, a newly published paper from the International Advisory Committee on Clinical Trials in Multiple Sclerosis suggests that patients with MS have qualitatively similar pathological features, independent of clinical course, and that disability progression is … Read more

Christina Applegate appears for star ceremony on the Hollywood Walk of Fame

Christina Applegate has made her first public appearance since announcing her multiple sclerosis diagnosis last year. The 50-year-old American actress, who revealed last week that she hadn’t been out since August 2021, attended a ceremony on Tuesday to receive her star on Hollywood’s coveted Walk of Fame. Walking with the help of a cane, a … Read more

Mental health of doctors; MS therapy program; and HPV vaccines

Too few doctors are seeking mental health care Doctors face high stress and high rates of depression and suicide, yet too few seek mental health care, lawyers argue. Stigma and fear of reprisal keep medical professionals from seeking such care, they say. Yet 11% of female physicians and 9% of male physicians said they have … Read more

Christina Applegate’s MS Battle: Photos Show Star On Dead To Me Set

Photos of Christina Applegate on the set of her hit Netflix series Dead To Me reveal the health problems the actress has been dealing with since her diagnosis of multiple sclerosis. It comes after Applegate gave a candid new interview with The New York Times this week, in which she outlined the effects of the … Read more

Obesity management likely to improve clinical outcome of MS

Carrying far too much weight in a diagnosis of MS (multiple sclerosis) is linked to higher current and subsequent levels of disability within a relatively short period of time, finds research published online in the Journal of Neurology Neurosurgery and Psychiatry. Returning to a healthy weight may improve clinical outcomes for obese patients with MS, … Read more

Christina Applegate had to ‘keep her legs up’ while filming Dead to Me with MS

Dead to Me star Christina Applegate has opened up about the obstacles she faced while filming the final run of her hit Netflix show as she battled multiple sclerosis, revealing she was unable to live without a cane. walking and that she had to “keep her legs up” by crew members. The 50-year-old actress was … Read more

Christina Applegate Prepares to Leave for First Time Since MS Diagnosis

Christina Applegate gears up for her first major public appearance since she was diagnosed with multiple sclerosis last year. The 50-year-old actress took Twitter on Friday to share a photo of the walking sticks she plans to use during the event, New York Post reports. “I have a very important ceremony coming up,” she wrote … Read more

Researchers develop new method to calculate delay of signal propagation in brains of MS patients

Researchers from the Human Brain Project have developed a new methodology to calculate the delay in signal propagation in the brains of patients suffering from multiple sclerosis, a chronic inflammatory disease that affects more than 2 million people worldwide. The results are published in the Journal of Neuroscience by researchers from the Institut de Neurosciences … Read more

Unique compound of CNM-Au8 to treat MS and ALS: Michael Hotchkin

WATCH TIME: 2 minutes “It’s fascinating how many different neurodegenerative diseases share a commonality of energetic dysfunction. We have preclinical models that suggest efficacy for a variety of different neurodegenerative diseases: MS, ALS, Alzheimer’s disease and multiple other models.” CNM-Au8, an investigational agent consisting of a gold nanocrystal suspension developed by Clene Nanomedicine, represents a … Read more